We are live on ! Find out more
MEDP icon

Medpace

113 hedge funds and large institutions have $311M invested in Medpace in 2017 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 41 increasing their positions, 20 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

270% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 10

241% more capital inflows, than outflows

Capital inflows: $101M | Capital outflows: $29.5M

105% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 20

31% more funds holding

Funds holding: 86 → 113 (+27)

6.09% more ownership

Funds ownership: 16.2% → 22.29% (+6.1%)

Holders
113
Holders Change
+27
Holders Change %
+31.4%
% of All Funds
2.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
37
Increased
41
Reduced
20
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MEDP Hedge Fund Activity: Q4 2017 in Review

113 of the 4,420 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q4 2017, worth a combined $311M — up 52% from $204M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new MEDP positions and 10 closed out — a net gain of 27 holders — while 41 added to existing stakes and 20 trimmed.

The largest buyer was BlackRock, adding an estimated $22.7M. The largest seller was Redmile Group, exiting entirely with an estimated $15.9M sold.

  • 113 institutional investors held Medpace (MEDP) as of Q4 2017, up from 86 in Q3 2017.
  • Funds reported $311M of Medpace stock for Q4 2017, up 52% quarter-over-quarter.
  • 37 funds opened new Medpace positions in Q4 2017 and 10 closed out, a net change of +27 holders.
  • The largest Medpace buyer in Q4 2017 was BlackRock, an estimated $22.7M added.
  • The largest Medpace seller in Q4 2017 was Redmile Group, an estimated $15.9M sold.

Based on aggregated 13F filings for Q4 2017.